
==== Front
Ital J Pediatr
Ital J Pediatr
Italian Journal of Pediatrics
1824-7288
BioMed Central London

39294711
1763
10.1186/s13052-024-01763-1
Research
The overlapping of phenotypes in Wiedemann-Steiner, Kleefstra and Coffin-Siris syndromes: a study of eleven patients
Prada Elisabetta 12
http://orcid.org/0000-0002-6574-9608
Meossi Camilla camimeossi@yahoo.it

13
Marafon Denise Piras 1
Grilli Federico 1
Scuvera Giulietta 1
Marchisio Paola Giovanna 14
Agostoni Carlo Virginio 14
Natacci Federica 1
Milani Donatella 1
1 https://ror.org/016zn0y21 grid.414818.0 0000 0004 1757 8749 Fondazione IRCSS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
2 grid.416317.6 0000 0000 8897 2840 Ospedale Sant’Anna, ASST Lariana, Como, Italy
3 Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy
4 https://ror.org/00wjc7c48 grid.4708.b 0000 0004 1757 2822 Università degli Studi di Milano, Milano, Italy
19 9 2024
19 9 2024
2024
50 18721 12 2023
8 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background

Some chromatinopathies may present with common clinical findings (intellectual disability, brain and limb malformation, facial dysmorphism). Furthermore, one of their cardinal shared features is growth dysregulation.We aimed to assess and deepen this resemblance in three specific conditions, namely Wiedemann-Steiner (WDSTS), Kleefstra (KLEFS1) and Coffin-Siris syndrome (CSS1), with a particular focus on possible metabolic roots.

Methods

Eleven patients were enrolled, three with WDSTS, five with KLEFS1 and three with CSS1, referring to Fondazione IRCCS Ca’ Granda Ospedale Maggiore, Milan, Italy. We performed both a physical examination with detailed anthropometric measurements and an evaluation of the patients’ REE (rest energy expenditure) by indirect calorimetry, comparing the results with age- and sex-matched healthy controls.

Results

We observed new clinical features and overlap between these conditions suggesting that different disturbances of epigenetic machinery genes can converge on a common effect, leading to overlapping clinical phenotypes.
The REE was not distinguishable between the three conditions and healthy controls.

Conclusions

Epigenetic machinery plays an essential role both in growth regulation and in neurodevelopment; we recommend evaluating skeletal [craniovertebral junction abnormalities (CVJ) polydactyly], otolaryngological [obstructive sleep apnea syndrome (OSAs), recurrent otitis media], dental [tooth agenesis, talon cusps], and central nervous system (CNS) [olfactory bulbs and cerebellum anomalies] features. These features could be included in monitoring guidelines. Further studies are needed to deepen the knowledge about energy metabolism.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13052-024-01763-1.

Keywords

Intellectual disability
Chromatinopathies
KMT2A gene
EHMT1 gene
ARID1B gene
Rest energy expenditure
Indirect calorimetry
Epigenetic machinery
http://dx.doi.org/10.13039/501100003196 Ministero della Salute Ministero della Salute issue-copyright-statement© Società Italiana di Pediatria 2024
==== Body
pmcBackground

Wiedemann-Steiner syndrome (WDSTS, OMIM #605130), Kleefstra syndrome type 1 (KLEFS1, OMIM #610253) and Coffin-Siris syndrome type 1 (CSS1, OMIM #135900) are ultra-rare genetic conditions associated with mutations in epigenetic regulating genes [1].

While these syndromes have been individually studied, there is a relative lack of comparative studies that analyze them together. This comparative approach enhances our understanding of the underlying pathways and improves diagnostic accuracy and therapeutic strategies for these chromatinopathies.WDSTS is mainly characterized by prenatal and postnatal growth delay, from mild to moderate intellectual disability (ID), localized (cubiti, back, limbs) hypertrichosis, facial dysmorphisms (thick eyebrows, long eyelashes, down-slanting palpebral fissures, hypertelorism, wide nasal bridge and thin lips) and possible cardiac, renal and ocular defects. This condition has been linked to heterozygous mutations in KMT2A gene (OMIM *159555) [2].

A typical facies (synophrys/arched eyebrows, up-slanting palpebral fissures, hypertelorism, bulbous nasal tip, midface retrusion, protruding tongue, thick mouth and everted lower lip), microbrachycephaly, hypotonia and speech delay, growth retardation, cardiac defects and moderate to severe ID are typical of KLEFS1 [3], and the diagnosis is established in probands with heterozygous deletions on chromosome 9q34.3 including at least part of EHMT1 gene (50% of cases) or intragenic EHMT1 pathogenic variants (50%) [4].

CSS1 patients share the following features: a coarse face, aplasia/hypoplasia of the distal phalanx of the fifth finger and/or absence of the nail, ID of variable degree, growth delay, hypertrichosis, sparse scalp hair, possible malformations of cardiac, genitourinary, gastrointestinal and central nervous systems [5]. Heterozygous mutations in ARID1B gene (OMIM *614556) are associated with CSS1.

From a functional point of view, the proteins encoded by the aforementioned genes belong to four different classes of enzymes, each of which participates in the regulation of the chromatin structure and in trascriptional activity [1]. Sebastian et al. suggest that the dysregulation of epigenetic mechanisms can account for several pathologies and contribute to metabolism-associated diseases [6]. The somatic growth is a dynamic process strongly correlated to the energy metabolism. The total energy expenditure (TEE) has three main components: thermogenesis, physical activity and basal metabolic rate (BMR). The latter is the minimal amount of the energy necessary for the preservation of the human homeostasis and amounts to about 40–70% of the TEE. Different factors may affect the BMR, first of all somatic growth; other ones are body surface, body composition, age, sex, ethnicity, body temperature, diet and hormone status. In the clinical practice, the BMR is usually interchangeable with the rest energy expenditure (REE), which is about 10% higher than the BMR and could be measured by indirect calorimetry [7].

In an interesting way, all the aforementioned conditions are mainly characterized by growth delay, albeit with some differences: in all cases a short stature may be typical; however, KLEFS1 individuals commonly become overweight during adolescence, while weight is low or normal in WDSTS and CSS1 [8]. Based on these assumptions, in this paper we describe the clinical features of a group of WDSTS, KLEFS1, and CSS1 patients looking for new and/or overlapping peculiar findings, and assessing their growth pattern to deepen the knowledge of the possible etiopathogenetic determinants. To this purpose, for the first time we investigate the energy metabolism of these syndromes by the evaluation of both anthropometric measurements and REE assessment.

Overall, combining anthropometric measurements with indirect calorimetry provides a comprehensive evaluation of an individual’s energy metabolism and growth status, which is crucial for diagnosing and managing genetic syndromes with metabolic implications.

Methods

We enrolled pediatric subjects with a clinical and molecular diagnosis of WDSTS, KLEFS1, and CSS1 referred to the outpatient genetic clinic of Fondazione IRCCS Ca’ Granda Ospedale Maggiore, Milan. Genetic analyses, familial, perinatal and childhood history, developmental and cognitive assessment, any other clinical and diagnostic evaluation were collected (Tables 1 and 1S ). A thorough physical examination was then performed with anthropometric measurements and evaluation of REE by indirect calorimetry (Table 2 ). The anthropometric measurements included weight (W), height (H), body mass index (BMI), occipitofrontal (OFC), arm and abdominal circumferences, and bicipital, tricipital, subscapular and suprailiac folds. The indirect calorimetry was performed in the morning, following an overnight fast, using Sensor-Medics Vmax SPECTRA, Milan, Italy. During the exam, each individual had to breathe under a canopy mask for 20–30 min while remaining awake and quiet. The REE values of all patients were compared with the REE of age- and sex-matched healthy controls.

Table 1 Comparison of key clinical features between study patients and literature reports

Feature	WDSTS (Study, 3 patient)	WDSTS (Literature)	KLEFS1 (Study, 5 patient)	KLEFS1 (Literature)	CSS1 (Study, 3 patient)	CSS1 (Literature)	
Genetic Mutations	c.3294G > A, c.3461G > A, c.6873delG in KMT2A	> 90% KMT2A mutations	Microdeletions (4 patients) and missense mutations (1 patient) in EHMT1	80–85% deletions,

20–25% mutations in EHMT1

	c.5049del, c.3826G > T, c.6164G > A in ARID1B	68–83% ARID1B mutations	
Facial Dysmorphisms	Present in all patients	> 80% prevalence	Present in all patients	95% prevalence	Present in all patients	> 90% prevalence	
Hypertrichosis	Observed in 2 out of 3 patients	60% prevalence	Not observed	Rare	Present in all patients	60% prevalence	
Developmental Delay	Present in all patients	> 90% prevalence	Present in all patients	> 90% prevalence	Present in all patients	> 90% prevalence	
CNS Anomalies	Observed in 1 patient	~ 40% prevalence	CNS malformations in 3 patients	50% prevalence	CNS anomalies in 1 patient	50% prevalence	
Gastrointestinal Issues	Observed in 1 patient	60% prevalence	Observed in 2 patients	~ 30% prevalence	None reported	30% prevalence	
Genitourinary Anomalies	None observed	30% prevalence	None observed	Rare	1 patient with anomaly	35% prevalence	
Ocular Issues	Present in 2 patients	60% prevalence	None reported	Rare	Present in 2 patients	40% prevalence	
Dental Issues	Observed in 1 patient	~ 40% prevalence	None reported	Rare	Delayed dental eruption in 1 patient	40% prevalence	
Recurrent Infections	Observed in 1 patient	~ 40% prevalence	Recurrent infections in 2 patients	~ 30% prevalence	Frequent infections in 2 patients	60% prevalence	
Abbreviations: CNS = Central Nervous System

Table 2 Anthropometric measurements and energy expenditures in patients with WDSTS, KLEFS1 and CSS1

	WDSTS (N = 3)	KLEFS1 (N = 5)	CSS1 (N = 3)				
N	Median
(Q1;Q3)	N	Median
(Q1;Q3)	N	Median
(Q1;Q3)		
Weight (DS)	3	-0,59

(Q1 -1,72; 1,31)

	5	0,90

(0,76; 1,07)

	3	0,06

(-0,67; 0,35)

	
Height (DS)	3	-0,89

(-1,26; -0,83)

	5	-0,75

(-0,77; 0,63)

	3	-0,72

(-0,77; -0,14)

	
OFC (DS)	3	-2,41

(-2,46; -0,07)

	5	-1,44

(-1,81; -0,84)

	3	1,42

(1,07; 2,10)

	
BMI (DS)	3	-0,13

(-1,37; 2,14)

	5	1,47

(1,18; 2,07)

	3	0,95

(-0,28; 0,99)

	
Arm circumference (cm)	3	18,2

(16,7; 24,5)

	3	19,8

(16,2; 28,0)

	3	18,8

(16,5; 19,7)

	
Abdominal circumference (cm)	3	62,0

(Q1 52,3; 82,0)

	3	57,0

(48,5; 81,5)

	3	55,5

(48,5; 60,5)

	
Bicipital fold (mm)	3	12

(5; 18)

	3	14

(13; 15)

	3	10

(5; 5)

	
Tricipital fold (mm)	3	12

(8; 28)

	3	20

(20; 22)

	3	16

(15; 19)

	
Subscapolar fold (mm)	0	0	2	14,5

(12,0; 17,0)

	1	3

(3; 3)

	
Suprailiac fold (mm)	2	15

(5; 25)

	3	23

(20; 25)

	2	11,5

(8,0; 15,0)

	
REE (Kcal/die)	3	698

(611; 1348)

	5	740

(495; 1394)

	3	892

(846; 910)

	
Abbreviations: OFC = Occipital-Frontal Circumference; BMI = Body Mass Index; REE = Rest Energy Expenditure; DS = Deviation Standard; cm = centimetres; mm = millimetres

The statistical analysis was evaluated using STATA 15.1 software. We calculated the frequencies (number and percentile) for the qualitative variables and the median, the first (Q1) and the third (Q3) quartiles for the quantitative ones. We used the Mann-Whitney test to compare cases and controls. A p-value < 0,05 was considered statistically significant.

Results

We enrolled 11 patients, three with WDSTS, five with KLEFS1 and three with CSS1. Six patients were males (55%) and five were females (45%). The group’s median age was 7.1 years (Q3 3.8; Q5 8.2). All patients had a confirmed molecular diagnosis: mutations in the KMT2A gene were found in all WDSTS patients (Tables 1 and 1S); among KLEFS1, four patients had a chromosomal microdeletion partially or fully involving the EHMT1 gene (80%), while one had a point mutation in EHMT1 (20%) (Tables 1 and 1S ); all patients with CSS1 had mutations in ARID1B (Tables 1 and 1S ).

Hypertrichosis and neurodevelopmental disorders were evident in all WDSTS patients (Tables 1 and 1S ). Orthopaedic and otolaryngologic involvements were reported in two cases, while ocular, dental, gastrointestinal, and renal defects were found in only one subject. As expected, distinctive facial features (Fig. 1; Tables 1 and 1S ) and neurodevelopmental disorders were common in KLEFS1 group, associated with other clinical issues, especially involving the CNS and musculoskeletal system (four out of five patients). In the CSS1 sample, the cardinal features were present in all individuals (Fig. 2,), who also showed mild CNS malformations (hypolastic, short and dysplastic corpus callosum and small cerebellar vermis), ocular defects, and recurrent infections.

About growth and metabolism, WDSTS patients had a mildly delayed growth, with only microcephaly being significant; KLEFS1 patients presented normal growth but showed higher than normal abdominal fat; CSS1 individuals showed normal anthropometric parameters (Table 2). The indirect calorimetry gave reliable results in all patients with the exception of two cases in which the examination was interrupted due to sleep in one patient (patient 4), and the impossibility to maintain silence in the other one (patient 5).

No statistically significant difference was observed between patients and controls. (p-value = 0.69) (Fig. 3).

Fig. 1 Distinctive facial features in KLEFS1 patient (widely spaced eyes, synophrys, midface retrusion, protruding tongue, eversion of the vermilion of the lower lip, and prognathism of chin)

Fig. 2 Distinctive facial features in CSS patient (sparse scalp hair, long eyelashes, bulbous nasal tip, anteverted and posteriorly rotated ears, thick and everted lower lip)

Fig. 3 Comparison between the REE of the 11 patients and the 11 age- and sex-matched controls. No statistically significant difference was observed between cases and controls (p-value = 0.69)

Discussion

Different disorders of epigenetic machinery often show common clinical findings; one of the shared cardinal features is undoubtedly growth dysregulation. Based on these assumptions, we compared patients with three Cromathinopaties, searching for overlapping features and investigating metabolism and growth-related issues.

The main diagnostic clues in WDSTS and CSS1 patients are minor anomalies; localized or diffuse hypertrichosis for both and a tiny hypoplasia of the fifth fingernail along with mild specific dysmorphisms such as bulbous nasal tip, thick and everted lower lip for CSS1 [2, 5, 8, 9]. The low clinical burden of these pathognomonic signs carries a risk of an underestimation of cases; when considering KLEFS1 group, we observed instead that the age at diagnosis was lower compared to the other syndromes. A possible explanation could be that most KLEFS1 cases are detected by array-Comparative Genomic Hybridization (a-CGH), which is still often the first-tier genetic test in patients with psychomotor delay. Furthermore we propose that the earlier age at diagnosis observed in KLEFS1 patients could be due to their more pronounced phenotype and the early onset of clear clinical manifestations. This explanation is supported by similar findings in another epigenetic machinery disorder, specifically Sotos Syndrome (SS type 1, OMIM #117550; type 2, OMIM #614753) [14]. In SS, as in KLEFS1, the distinct and early-developing features lead to earlier recognition and diagnosis.

Analyzing the data to highlight overlaps or other signs useful for diagnosis, we noticed a high percentage of WDSTS patients with bone abnormalities, mainly represented by a cervical fusion Klippel Feil-like (2/3; 67%). CVJ and cervical vertebral abnormalities have been recently described in WDSTS patients [9], and are reported in another epigenetic machinery disorder (Rubinstein-Taybi syndrome, RSTS type 1, OMIM # 180849; type 2, OMIM # 613684) [10]. A further skeletal feature previously outlined in RSTS is preaxial polydactyly. Yu et al. reported polydactyly and syndactyly in nine out of 17 patients with RSTS (37%), with the postaxial polydactyly being more frequent (80%) than the preaxial (20%) in contrast with previous studies [11]. One KLEFS1 patient had a right foot postaxial polydactyly, a peculiar finding, even though extremity abnormalities are commonly described in KLEFS1 patients, mostly being broad toes, syndactyly, clinodactyly and brachydactyly [12].

Moreover, we found two WDSTS patients with adenoid hypertrophy and obstructive sleep apnea (OSA). These clinical features are present in other disorders of Epigenetic Machinery such as RSTS [13] and SS [14].

In all these conditions, OSAs, resulting from a combination of craniofacial dysmorphisms (arched and narrow palate, micrognathia in WDSTS and RSTS while prognathism in SS), easy collapsibility of the laryngeal walls or laryngomalacia, obesity and global hypotonia, can become a major issue, such as during anesthetic procedures. These patients are therefore usually assessed by the otolaryngologist and, if necessary, promptly treated [13, 14]. Three KLEFS1 patients had recurrent otitis media, which has never been reported in this syndrome but frequently described in other epigenetic disorders, such as RSTS [13], SS [14] and CSS1 [5]. Recurrent upper airway infections in these conditions might be facilitated by the anatomic craniofacial conformation and by a peculiar immune status. The latter’s contribution is still being evaluated: Saettini et al. observed immunological abnormalities in about half of 97 RSTS patients, ranging from antibody defects to primary immunodeficiency [15].

Dental abnormalities, such as talon cusps and the absence of molar teeth, were found in our cohort and have been previously described in RSTS1, SS1 and CSS1. These dental abnormalities could also be considered non-invasive signs of Epigenetic Machinery-related disorders.

In addition, we found a bilateral olfactory bulb hypoplasia in one of our KLEFS1 patients. Involvement of the olfactory bulbs is typically associated with CHARGE syndrome (OMIM #214800) [16], another epigenetic disorder caused by mutations in CHD7 gene (OMIM *608892) [17]. Olfactory anomalies have also been reported in nine of 16 patients with RSTS [10] and in one of 11 patients with Weaver syndrome, (WVS; OMIM #277590), caused by germline pathogenic variants in EZH2. WVS is a Mendelian disorder characterized by striking overgrowth intellectual disability and distinctive facies [17]. Studies performed on knockout mouse models demonstrated that mutations during the early development in EHMT1, CHD7, and CREBBP (associated with RSTS type 1; OMIM *600140) disrupt the proliferation and the migration of the olfactory epithelium resuling in a size reduction of the olfactory bulbs [18]. Furthermore, as in our cohort, brain Magnetic Resonance Image (MRI) scans of RSTS patients show a high rate (73,6% and 57,8%, respectively) of abnormalities of the corpus callosum and some malformations of the posterior cranial fossa (especially small cerebellar vermis), suggesting a widely overlapped spectrum among these disorders [10].

Lastly, in our cohort of KLEFS1 one patient developed a delay in the right branch conduction, stressing the role of periodic instrumental heart exams even if a first cardiologic evaluation resulted normal; while in our sample of CSS1 one patient had gluten-sensitive enteropathy which may not be linked with the disease, also due to its high incidence in the general population.

Regarding growth and metabolism, the REE measured in our cohort did not significantly differ from that of the age- and sex-matched control group. It should be considered, however, that, although growth impairment is quite common in all these conditions, the trend over time is variable: subjects with WDSTS have both prenatal and post-natal growth delay [2]; individuals with KLEFS1 have short stature and usually become overweight or obese after childhood [3]; patients with CSS1 grow at the lower limits for weight and/or height [5]. Over the last few years, the links between epigenetics and cellular metabolism have been the topics of many studies; impaired epigenetic regulatory mechanisms in cellular metabolism can affect the physiological balance, potentially contributing to diseases. These issues have been studied particularly for obesity, cancer and diabetes [7]. There are no comparable studies, however, regarding chromatinopathies or other growth alteration diseases [19, 20]. Conversely, the energy metabolism has been investigated in other genetic disorders, with contrasting results. Kaplan et al. [21] observed that the REE of six subjects with Williams-Beuren syndrome (WBS, OMIM #194050) was higher than in age- and sex-matched controls. Increased REE values were also reported by Leoni et al. [22] in 11 individuals with Costello syndrome (CSTLO, OMIM #218040). In contrast, patients with Prader-Willi syndrome (PWS, OMIM #176270) showed lower values of energy expenditure [23]. Our cohort’s heterogeneity and the control group’s selection might represent a bias in our evaluation [24]. Indeed, while individuals with WBS and CSTLO may have a lipodystrophic appearance [21, 22] subjects with WDSTS, KLEFS1 and CSS1 have a normal fat distribution (Table 2 ). Assessing fat mass, fat-free mass and their ratios could help evaluate the calorimetric findings in patients with various genetic syndromes.

Conclusions

We collected the clinical features of a cohort of patients with WDSTS, KLEFS1 and CSS1, observing an intriguing and mazy overlap between these and other disorders of the epigenetic machinery. This prompts us to make some suggestions on the development of diagnostic clues. We suggest that skeletal (CVJ abnormalities, polydactyly), otolaryngological (OSAs, recurrent otitis media), dental (tooth agenesis, talon cusps) and CNS (olfactory bulbs and cerebellum anomalies) features should be investigated and valued in the occurrence of a clinical non-specific hypothesis of chromathinopaty. Prospectively, some of these features could also be considered in the monitoring guidelines of these conditions. Furthermore, this is the first study to investigate the energy expenditure in these conditions, underlining the role of an accurate instrumental evaluation for the purposes of individualized follow-up and the prevention of complications [25–27]. The absence of significant differences in REE between patients and controls makes further studies essential to deepen the knowledge on the impact of chronic conditions as regards metabolic functions over time. Including additional clinical parameters, such as fat distribution and other measurements, could be crucial for a more comprehensive understanding of the patient’s condition. Furthermore, variations in REE could emerge with aging, making regular assessments helpful for a better understanding. In conclusion, also due to the limited sample size, further studies are required to more accurately assess the energy metabolism of these ultra-rare conditions.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Acknowledgements

One of the authors of this publication (DM) is a member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA [EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516].

Author contributions

E.P and C.M composed the main structure of the manuscript and designed and prepared the clinical tables. D. P. M contributed in performing statistical analysis. F.G., G.S., D.M provided the clinical investigations and oversaw all follow-up with the families. P.G.M., C.V.A., F.N., D.M supervised all the study. All authors read and approved the manuscript.

Funding

This study was partially funded by Italian Ministry of Health.

Data availability

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore (committee’s reference number 135/2013) and was conducted following Good Clinical Practice guidelines. Written informed consent was obtained from the parents of the patients for publication of the details of his medical case. All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.

Consent for publication

Written informed consent was obtained from the parents of the patients for publication of the details of his medical case.

Competing interests

The authors declare that they have no competing interests.

Abbreviations

a-CGH array-Comparative Genomic Hybridization

BMR basal metabolic rate

BMI body mass index

CNS Central Nervous System

CSS1 Coffin-Siris syndrome type 1

CSTLO Costello syndrome

CVJ craniovertebral junction

H height

ID intellectual disability

KLEFS1 Kleefstra syndrome type 1

MRI Magnetic Resonance Image

OFC occipitofrontal circumference

OSAS obstructive sleep apnea syndrome

PWS Prader-Willi syndrome

REE rest energy expenditure

RSTS Rubinstein-Taybi syndrome

SPECTRA Sensor-Medics Vmax

SS Sotos syndrome

TEE total energy expenditure

WVS Weaver syndrome

W weight

WDSTS Wiedemann-Steiner syndrome

WBS Williams-Beuren syndrome

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Elisabetta Prada and Camilla Meossi contributed equally to this work and share first authorship.
==== Refs
References

1. Harris JR, Gao CW, Britton JF, Applegate CD, Bjornsson HT, Fahrner JA. Five years of experience in the epigenetics and chromatin clinic: what have we learned and where do we go from here? Hum Genet. 2023 Mar 23:1–18. 10.1007/s00439-023-02537-1. Epub ahead of print. PMID: 36952035; PMCID: PMC10034257.
2. Ng R Bjornsson HT Fahrner JA Harris J Associations between executive functioning, behavioral functioning, and adaptive functioning difficulties in Wiedemann-Steiner Syndrome Arch Clin Neuropsychol 2024 39 2 186 95 10.1093/arclin/acad060 37565480
Ng R, Bjornsson HT, Fahrner JA, Harris J. Associations between executive functioning, behavioral functioning, and adaptive functioning difficulties in Wiedemann-Steiner Syndrome. Arch Clin Neuropsychol. 2024;39(2):186–95. 10.1093/arclin/acad060. PMID: 37565480; PMCID: PMC10879922.37565480
3. Rots D, Choufani S, Faundes V, Dingemans AJM, Joss S, Foulds N, Jones EA, Stewart S, Vasudevan P, Dabir T, Park SM, Jewell R, Brown N, Pais L, Jacquemont S, Jizi K, Ravenswaaij-Arts CMAV, Kroes HY, Stumpel CTRM, Ockeloen CW, Diets IJ, Nizon M, Vincent M, Cogné B, Besnard T, Kambouris M, Anderson E, Zackai EH, McDougall C, Donoghue S, O’Donnell-Luria A, Valivullah Z, O’Leary M, Srivastava S, Byers H, Leslie N, Mazzola S, Tiller GE, Vera M, Shen JJ, Boles R, Jain V, Brischoux-Boucher E, Kinning E, Simpson BN, Giltay JC, Harris J, Keren B, Guimier A, Marijon P, Vries BBA, Motter CS, Mendelsohn BA, Coffino S, Gerkes EH, Afenjar A, Visconti P, Bacchelli E, Maestrini E, Delahaye-Duriez A, Gooch C, Hendriks Y, Adams H, Thauvin-Robinet C, Josephi-Taylor S, Bertoli M, Parker MJ, Rutten JW, Caluseriu O, Vernon HJ, Kaziyev J, Zhu J, Kremen J, Frazier Z, Osika H, Breault D, Nair S, Lewis SME, Ceroni F, Viggiano M, Posar A, Brittain H, Giovanna T, Giulia G, Quteineh L, Zonneveld-Huijssoon R, Mellado E, Marey C, Coudert I, Aracena Alvarez A, Kennis MI, Bouman MGP, Roifman A, Amorós M, Ortigoza-Escobar RodríguezMI, Vernimmen JD, Sinnema V, Pfundt M, Brunner R, Vissers HG, Kleefstra LELM, Weksberg T, Banka R. Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes. Am J Hum Genet. 2024 Jul;9. S0002-9297(24)00215-5. Epub ahead of print. PMID: 39013459.
4. Burger P Colin F Strehle A GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodevelopmental disorders J Neural Transm (Vienna) 2023 130 3 459 71 10.1007/s00702-022-02569-3 36436153
Burger P, Colin F, Strehle A, et al. GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodevelopmental disorders. J Neural Transm (Vienna). 2023;130(3):459–71. 10.1007/s00702-022-02569-3. Epub 2022 Nov 27. PMID: 36436153; PMCID: PMC9702708.36436153
5. Schmetz A Lüdecke HJ Surowy H Sivalingam S Bruel AL Caumes R Charles P Chatron N Chrzanowska K Codina-Solà M Colson C Cuscó I Denommé-Pichon AS Edery P Faivre L Green A Heide S Hsieh TC Hustinx A Kleinendorst L Knopp C Kraft F Krawitz PM Lasa-Aranzasti A Lesca G López-González V Maraval J Mignot C Neuhann T Netzer C Oehl-Jaschkowitz B Petit F Philippe C Posmyk R Putoux A Reis A Sánchez-Soler MJ Suh J Tkemaladze T Tran Mau Them F Travessa A Trujillano L Valenzuela I van Haelst MM Vasileiou G Vincent-Delorme C Walther M Verde P Bramswig NC Wieczorek D Delineation of the adult phenotype of coffin-Siris syndrome in 35 individuals Hum Genet 2024 143 1 71 84 10.1007/s00439-023-02622-5 38117302
Schmetz A, Lüdecke HJ, Surowy H, Sivalingam S, Bruel AL, Caumes R, Charles P, Chatron N, Chrzanowska K, Codina-Solà M, Colson C, Cuscó I, Denommé-Pichon AS, Edery P, Faivre L, Green A, Heide S, Hsieh TC, Hustinx A, Kleinendorst L, Knopp C, Kraft F, Krawitz PM, Lasa-Aranzasti A, Lesca G, López-González V, Maraval J, Mignot C, Neuhann T, Netzer C, Oehl-Jaschkowitz B, Petit F, Philippe C, Posmyk R, Putoux A, Reis A, Sánchez-Soler MJ, Suh J, Tkemaladze T, Tran Mau Them F, Travessa A, Trujillano L, Valenzuela I, van Haelst MM, Vasileiou G, Vincent-Delorme C, Walther M, Verde P, Bramswig NC, Wieczorek D. Delineation of the adult phenotype of coffin-Siris syndrome in 35 individuals. Hum Genet. 2024;143(1):71–84. 10.1007/s00439-023-02622-5. Epub 2023 Dec 20. PMID: 38117302.38117302
6. Sebastian C Vong JSL Mayekar MK Tummala KS Singh I Editorial: metabolism and epigenetics Front Genet 2022 13 877538 10.3389/fgene.2022.877538 35360874
Sebastian C, Vong JSL, Mayekar MK, Tummala KS, Singh I. Editorial: metabolism and epigenetics. Front Genet. 2022;13:877538. 10.3389/fgene.2022.877538.35360874
7. Psota T Chen KY Measuring energy expenditure in clinical populations: rewards and challenges Eur J Clin Nutr 2013 67 5 436 42 10.1038/ejcn.2013.38 23443826
Psota T, Chen KY. Measuring energy expenditure in clinical populations: rewards and challenges. Eur J Clin Nutr. 2013;67(5):436–42.23443826
8. Kosho T Miyake N Carey JC Coffin-Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: historical review and recent advances using next generation sequencing Am J Med Genet Parts C Seminars Med Genet 2014 166C 3 241 51 10.1002/ajmg.c.31415
Kosho T, Miyake N, Carey JC. Coffin-Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: historical review and recent advances using next generation sequencing. Am J Med Genet Parts C Seminars Med Genet. 2014;166 C(3):241–51. 10.1002/ajmg.c.31415.
9. Giangiobbe S, Caraffi SG, Ivanovski I, et al. Expanding the phenotype of Wiedemann-Steiner syndrome: craniovertebral junction anomalies. Am J Med Genet Part A. 2020;1–10. 10.1002/ajmg.a.61859.
10. Ajmone PF Avignone S Gervasini C Rubinstein-Taybi syndrome: New Neuroradiological and neuropsychiatric insights from a multidisciplinary approach Am J Med Genet Part B Neuropsychiatric Genet 2018 177 4 406 15 10.1002/ajmg.b.32628
Ajmone PF, Avignone S, Gervasini C, et al. Rubinstein-Taybi syndrome: New Neuroradiological and neuropsychiatric insights from a multidisciplinary approach. Am J Med Genet Part B Neuropsychiatric Genet. 2018;177(4):406–15. 10.1002/ajmg.b.32628.
11. Yu S Wu B Qian Y Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese rubinstein-taybi syndrome kids with high frequency of polydactyly Mol Genetic Genomic Med 2019 7 12 e1009 10.1002/mgg3.1009
Yu S, Wu B, Qian Y, et al. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese rubinstein-taybi syndrome kids with high frequency of polydactyly. Mol Genetic Genomic Med. 2019;7(12):e1009. 10.1002/mgg3.1009.
12. Ciaccio C Scuvera G Tucci A New insights into Kleefstra Syndrome: report of two novel cases with previously unreported features and literature review Cytogenetic Genome Resourch 2018 156 3 127 33 10.1159/000494532
Ciaccio C, Scuvera G, Tucci A, et al. New insights into Kleefstra Syndrome: report of two novel cases with previously unreported features and literature review. Cytogenetic Genome Resourch. 2018;156(3):127–33. 10.1159/000494532.
13. Milani D Manzoni FM Pezzani L Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management Ital J Pediatr 2015 41 4 10.1186/s13052-015-0110-1 25599811
Milani D, Manzoni FM, Pezzani L, et al. Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management. Ital J Pediatr. 2015;41:4. 10.1186/s13052-015-0110-1.25599811
14. Gaudreau P Zizak V Gallagher TQ The otolaryngologic manifestations of Sotos syndrome Int J Pediatr Otorhinolaryngol 2013 77 11 1861 3 10.1016/j.ijporl.2013.08.029 24060089
Gaudreau P, Zizak V, Gallagher TQ. The otolaryngologic manifestations of Sotos syndrome. Int J Pediatr Otorhinolaryngol. 2013;77(11):1861–3. 10.1016/j.ijporl.2013.08.029.24060089
15. Saettini F Herriot R Prada E Prevalence of immunological defects in a cohort of 97 Rubinstein–Taybi Syndrome patients J Clin Immunol 2020 40 851 60 10.1007/s10875-020-00808-4 32594341
Saettini F, Herriot R, Prada E, et al. Prevalence of immunological defects in a cohort of 97 Rubinstein–Taybi Syndrome patients. J Clin Immunol. 2020;40:851–60. 10.1007/s10875-020-00808-4.32594341
16. de Geus CM Free RH Verbist BM Guidelines in CHARGE syndrome and the missing link: cranial imaging Am J Med Genet Part C Seminaries Med Genet 2017 175 4 450 64 10.1002/ajmg.c.31593
de Geus CM, Free RH, Verbist BM, et al. Guidelines in CHARGE syndrome and the missing link: cranial imaging. Am J Med Genet Part C Seminaries Med Genet. 2017;175(4):450–64. 10.1002/ajmg.c.31593.
17. Aleo S Cinnante C Avignone S Olfactory malformations in mendelian disorders of the Epigenetic Machinery Front Cell Dev Biol 2020 8 710 10.3389/fcell.2020.00710 32850830
Aleo S, Cinnante C, Avignone S, et al. Olfactory malformations in mendelian disorders of the Epigenetic Machinery. Front Cell Dev Biol. 2020;8:710. 10.3389/fcell.2020.00710.32850830
18. Schoof M Launspach M Holdhof D The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration Acta Neuropathol Commun 2019 7 1 199 10.1186/s40478-019-0849-5 31806049
Schoof M, Launspach M, Holdhof D, et al. The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration. Acta Neuropathol Commun. 2019;7(1):199. 10.1186/s40478-019-0849-5.31806049
19. Serra G Antona V Schierz M Vecchio D Piro E Corsello G Esophageal atresia and Beckwith-Wiedemann syndrome in one of the naturally conceived discordant newborn twins: first report Clin Case Rep 2018 6 2 399 401 10.1002/ccr3.1103 29445485
Serra G, Antona V, Schierz M, Vecchio D, Piro E, Corsello G. Esophageal atresia and Beckwith-Wiedemann syndrome in one of the naturally conceived discordant newborn twins: first report. Clin Case Rep. 2018;6(2):399–401.29445485
20. Cardio-facio-cutaneous syndrome And gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP2K2 gene. Gregorio Serra, Sofia Felice, Vincenzo Antona, Maria Rita Di Pace, Mario Giuffrè, Ettore Piro, Giovanni Corsello Ital J Pediatr 2022 48 65 35509048
Cardio-facio-cutaneous syndrome. And gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP2K2 gene. Gregorio Serra, Sofia Felice, Vincenzo Antona, Maria Rita Di Pace, Mario Giuffrè, Ettore Piro, Giovanni Corsello. Ital J Pediatr. 2022;48:65.35509048
21. Kaplan AS Stallings VA Zemel BS Green KA Kaplan P Body composition, energy expenditure, and energy intake in patients with Williams syndrome J Pediatr 1998 132 2 223 7 10.1016/s0022-3476(98)70435-4 9506631
Kaplan AS, Stallings VA, Zemel BS, Green KA, Kaplan P. Body composition, energy expenditure, and energy intake in patients with Williams syndrome. J Pediatr. 1998;132(2):223–7. 10.1016/s0022-3476(98)70435-4.9506631
22. Leoni C Onesimo R Giorgio V Understanding growth failure in Costello syndrome: increased resting energy expenditure J Pediatr 2016 170 322 4 10.1016/j.jpeds.2015.11.076 26778095
Leoni C, Onesimo R, Giorgio V, et al. Understanding growth failure in Costello syndrome: increased resting energy expenditure. J Pediatr. 2016;170:322–4. 10.1016/j.jpeds.2015.11.076.26778095
23. Alsaif M Elliot SA MacKenzie ML Energy Metabolism Profile in individuals with prader-Willi Syndrome and implications for Clinical Management: a systematic review Adv Nutritions 2017 8 6 905 15 10.3945/an.117.016253
Alsaif M, Elliot SA, MacKenzie ML, et al. Energy Metabolism Profile in individuals with prader-Willi Syndrome and implications for Clinical Management: a systematic review. Adv Nutritions. 2017;8(6):905–15. 10.3945/an.117.016253.
24. Grace C Beales P Summerbell C Energy metabolism in Bardet-Biedl syndrome Int J Obes Relat Metab Disord 2003 27 11 1319 24 10.1038/sj.ijo.0802420 14574341
Grace C, Beales P, Summerbell C, et al. Energy metabolism in Bardet-Biedl syndrome. Int J Obes Relat Metab Disord. 2003;27(11):1319–24. 10.1038/sj.ijo.0802420.14574341
25. Piro E Schierz IAM Antona V Neonatal hyperinsulinemic hypoglycemia: case report of kabuki syndrome due to a novel KMT2D splicing-site mutation Ital J Pediatr 2020 46 136 10.1186/s13052-020-00902-8 32948218
Piro E, Schierz IAM, Antona V, et al. Neonatal hyperinsulinemic hypoglycemia: case report of kabuki syndrome due to a novel KMT2D splicing-site mutation. Ital J Pediatr. 2020;46:136. 10.1186/s13052-020-00902-8.32948218
26. Serra G Memo L Antona V Jacobsen syndrome and neonatal bleeding: report on two unrelated patients Ital J Pediatr 2021 47 147 10.1186/s13052-021-01108-2 34210338
Serra G, Memo L, Antona V, et al. Jacobsen syndrome and neonatal bleeding: report on two unrelated patients. Ital J Pediatr. 2021;47:147. 10.1186/s13052-021-01108-2.34210338
27. Serra G Antona V D’Alessandro MM Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town Ital J Pediatr 2021 47 138 10.1186/s13052-021-01080-x 34134742
Serra G, Antona V, D’Alessandro MM, et al. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town. Ital J Pediatr. 2021;47:138. 10.1186/s13052-021-01080-x.34134742
